Easy RNAi control experiments using cell-death siRNA
January 29, 2008 QIAGEN's AllStars Hs Cell Death Control siRNA is the latest addition to the comprehensive AllStars portfolio of RNAi controls. Highly potent AllStars Hs Cell Death Control siRNA targets ubiquitous human cell survival genes. Transfection of this siRNA blend results in a high degree of cell death which is visible by light microscopy, making it an invaluable tool for siRNA transfection optimization and routine positive control experiments.
AllStars Hs Cell Death Control siRNA has been functionally validated in a wide range of human cell lines and primary cells. This control siRNA enables RNAi start-up experiments in which multiple transfections are performed to determine optimal conditions. In high-throughput RNAi screens, AllStars Hs Cell Death Control siRNA is ideal for use as an internal positive control to ensure that optimal transfection conditions are maintained on every plate. Simple phenotypic analysis using light microscopy to observe the extent of cell death is rapid and inexpensive.
AllStars Hs Cell Death Control siRNA can be ordered in tubes in 1-nmol, 5-nmol, or 20-nmol amounts, or in 96-well plates in 1-nmol, 0.25-nmol, or 0.1-nmol amounts.
Discover more about QIAGEN's wide range of validated siRNA controls at www.qiagen.com/AllStars!
siRNA products are intended for research use. No claim or representation is intended to provide information for the diagnosis, prevention, or treatment of a disease.
Trademarks: QIAGEN® (QIAGEN Group). siRNA technology licensed to QIAGEN is covered by various patent applications, owned by the Massachusetts Institute of Technology, the Carnegie Institute of Washington, Alnylam Corporation, and others.